Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research find could reduce hospital infections
hospital
Bacteria resistant materials could reduce infections acquired through implanted medical devices such as intravenous tubes.
£2m funding given to study of materials that repel bacteria

Researchers who discovered a group of new materials capable of repelling bacteria have won £2 miliion of funding to learn more about their find.

University of Nottingham's Morgan Alexander, Professor of Biomedical Surfaces in the School of Pharmacy, and Paul Williams, Professor of Molecular Microbiology in the School of Life Sciences, have received a Wellcome Trust Investigator Award for their joint project to understand why bacteria have taken such a dislike to their newly found polymers.

It's thought the bacteria resistant materials could lead to a significant decrease in hospital infections acquired through implanted medical devices, such as catheters, intravenous tubes and artificial joints, reducing the number of medical complications, lowering medical costs and saving thousands of lives a year.

Bacteria are attracted to implanted medical devices where they attach as single cells and grow as microcolonies where the bugs can hide to avoid detection and are protected from attack by the body’s own immune defences and antibiotics.

The Wellcome Trust research award will fund a centre of excellence that will study the underlying mechanisms behind the resistance the polymers show to bacterial attachment.

Professor Williams said: “Bacteria are highly adaptable micro-organisms and we need to discover the genetic basis of how they sense and respond to chemically distinct polymer surfaces. By combining our expertise in materials science and microbiology we are taking an interdisciplinary approach to solving a major medical problem.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.